2024 Logo CMT Convention - Social (White)

September 26-28, 2024
 Cambridge, MA




The CMT Research Foundation unites the voices of patients, researchers, pharma companies, and regulatory agencies to develop treatments for CMT.

This event takes place over three days. Thursday and Friday are scientific meetings meant for researchers and scientists working in CMT. Saturday is primarily for patients and their families and caregivers, providing a chance to interact with the research community that is working so hard on their behalf and to better understand the latest in research progress.

For the Scientific Community

September 26-27th

Two days for researchers, industry and government agencies to:

SHARE the latest in CMT drug development research

CREATE new connections and collaborations

EXAMINE the most pressing issues facing CMT drug development

Click here to see the full agenda


Click here to see the full day of event agenda

Chris Austin, MD, PhD

CEO-Partner of Flagship Pioneering,
Chief Executive Officer of Vesalius Therapeutics and
Founding Director of the National Center for Advancing Translational Sciences (NCATS)

Vera Fridman

University of Colorado

Rudolf Martini

University of Würzbug

Rachel Bailey

University of Texas Southwestern Medical Center

For the Patient Community

September 28th

A day for the patient community to:

LEARN about the latest developments and clinical trials in CMT

INTERACT with distinguished scientific experts and clinicians

ACT to speed treatments for patients and families

Click here to see the full agenda


Click here to see the full day of event agenda

Reza Seyedsadjadi, MD

Director, Charcot-Marie-Tooth (CMT) Center of Excellence, Massachusetts General Hospital
Assistant Professor of Neurology, Harvard Medical School

David Herrmann, MBBCh

Director, Charcot-Marie-Tooth (CMT) Center of Excellence, University of Rochester
Professor Department of Neurology, University of Rochester

Jim Lupski

Baylor College of Medicine

Katie Moss

Johns Hopkins University

Thomas Pedersen

NMD Pharma

Book your stay at the Royal Sonesta Boston with our special room rate here.









Thank you to our Sponsors!


Patient Day

Research Lunch



The Scientific Programming Committee

Charles Abrams, MD, PhD

Professor of Neurology and Rehabilitation

University of Illinois, Chicago (UIC)

Tiina Urv, PhD

Program Director, Office of Rare Diseases Research

U.S. National Center for Advancing Translational Sciences (NCATS)

Afrooz Rashnonejad, MSc, PhD

Principal Investigator, Center for Gene Therapy, Abigail Wexner Research Institute

Nationwide Children’s Hospital

Stephan Zuchner, MD, PhD, FANN

Professor of Human Genetics and Neurology

University of Miami Miller School of Medicine

Brett McCray, MD, PhD

Assistant Professor in Neurology

University of Michigan

If you have any questions please contact Vanessa Sanchez at

[email protected] or +1 (404) 474-8805